Actively Recruiting
Concentration Impact Nicotine Salt
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2025-03-28
312
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
Sponsors
I
Insel Gruppe AG, University Hospital Bern
Lead Sponsor
S
Swiss National Science Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Double-blind (for the two active arms), randomized, three-arm (two active and one control) clinical trial investigating factors (e.g. nicotine concentration) influencing the success of smoking cessation strategies and possible health risks related to nicotine salt vaping.
CONDITIONS
Official Title
Concentration Impact Nicotine Salt
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult (18 years or older) smokers who smoke at least 5 tobacco cigarettes per day for at least 12 months
- Motivated to quit smoking and willing to set a target quit date
- Exhaled carbon monoxide level of 10 ppm or higher, or saliva cotinine above 30 ng/ml if CO is borderline (6-10 ppm)
- Willing to participate even if assigned to the control group
- Able to communicate well with the investigator and follow study requirements
- Signed informed consent form
You will not qualify if you...
- Known allergy or hypersensitivity to any e-liquid ingredients
- Pregnant or breastfeeding women
- Planning to become pregnant during the study
- Current regular use of electronic cigarettes or tobacco heating systems
- Use of nicotine replacement therapy, varenicline, or bupropion within one month before screening
- Smoking tobacco combined with marijuana without intention to quit marijuana use
- Participation in another interventional trial within 30 days before screening
- Legal incapacity or limited capacity at screening
- Any condition that might affect study participation or compliance as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Inselspital
Bern, Switzerland
Actively Recruiting
Research Team
E
Evangelia Liakoni, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here